The North America Obesity Intervention Devices Market would witness market growth of 4.6% CAGR during the forecast period (2023-2029).
The rise in the number of medications launched for obesity intervention devices are the main factors driving the growth of the market. Obesity is characterized by an excess of body fat that has built up to the point that it is harmful to one's health. Typically, it is determined by a person's body mass index (BMI), which is computed using their height and weight.
Obesity is defined as a BMI of 30 or higher. By reducing how much food a person can comfortably eat, obesity intervention devices help people lose weight. Therefore, it is anticipated that the market will expand due to the rising prevalence of obesity. The market size is predicted to increase as the incidence of type 2 diabetes rises. The most typical kind of diabetes is type 2. Insulin resistance, which occurs when the body does not fully respond to insulin, is typically a defining feature.
Because insulin cannot function properly, blood glucose levels continue to increase, causing an increase in insulin release. Type 2 diabetes has obesity as a key risk factor. Insulin resistance, a major risk factor for type 2 diabetes, is more likely to develop in obese people. Chronic inflammation and obesity are related, and insulin resistance can result from chronic inflammation. Additionally, leptin is one hormone that is elevated in obese individuals and has been linked to a higher risk of type 2 diabetes.
Businesses should be concerned about the impact of unhealthy eating habits, inactivity, and obesity. Two out of every three adults in Canada are overweight or obese, according to Statistics Canada. Furthermore, over the past 25 years, there has been a significant rise in the prevalence of childhood obesity. With the exception of those in preschool, the increase was seen in both the male and female demographics and throughout all age groups. Additionally, to reach their full potential for growth and development, more than 50% of Canadian kids and teenagers do not participate in enough physical activity. As a result, it is anticipated that there will be greater demand for obesity intervention devices in the local market due to the rising prevalence of obesity among the population in the region.
The US market dominated the North America Obesity Intervention Devices Market by Country in 2022, and would continue to be a dominant market till 2029; thereby, achieving a market value of $89.7 million by 2029. The Canada market is poised to grow at a CAGR of 7% during (2023 - 2029). Additionally, The Mexico market would witness a CAGR of 6% during (2023 - 2029).
Based on End User, the market is segmented into Hospitals and Clinics & Others. Based on Device, the market is segmented into Gastric Bands, Gastric Balloon and Gastric Stimulation System. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Worldwide Obesity Intervention Devices Market is Projected to reach USD 352 Million by 2029, at a CAGR of 5.3%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson & Johnson, Apollo Endosurgery, Inc. (Boston Scientific Corporation), ReShape Lifesciences, Inc., AbbVie, Inc., Allurion Technologies, Inc., Spatz FGIA, Inc, Cousin Surgery, A.M.I. GmbH, ENDALIS, and GI Dynamics, Inc.
Scope of the Study
Market Segments Covered in the Report:
By End User
- Hospitals
- Clinics & Others
By Device
- Gastric Bands
- Gastric Balloon
- Gastric Stimulation System
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Johnson & Johnson
- Apollo Endosurgery, Inc. (Boston Scientific Corporation)
- ReShape Lifesciences, Inc.
- AbbVie, Inc.
- Allurion Technologies, Inc.
- Spatz FGIA, Inc
- Cousin Surgery
- A.M.I. GmbH
- ENDALIS
- GI Dynamics, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Obesity Intervention Devices Market, by End User
1.4.2 North America Obesity Intervention Devices Market, by Device
1.4.3 North America Obesity Intervention Devices Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Obesity Intervention Devices Market by End User
3.1 North America Hospitals Market by Country
3.2 North America Clinics & Others Market by Country
Chapter 4. North America Obesity Intervention Devices Market by Device
4.1 North America Gastric Bands Market by Country
4.2 North America Gastric Balloon Market by Country
4.3 North America Gastric Stimulation System Market by Country
Chapter 5. North America Obesity Intervention Devices Market by Country
5.1 US Obesity Intervention Devices Market
5.1.1 US Obesity Intervention Devices Market by End User
5.1.2 US Obesity Intervention Devices Market by Device
5.2 Canada Obesity Intervention Devices Market
5.2.1 Canada Obesity Intervention Devices Market by End User
5.2.2 Canada Obesity Intervention Devices Market by Device
5.3 Mexico Obesity Intervention Devices Market
5.3.1 Mexico Obesity Intervention Devices Market by End User
5.3.2 Mexico Obesity Intervention Devices Market by Device
5.4 Rest of North America Obesity Intervention Devices Market
5.4.1 Rest of North America Obesity Intervention Devices Market by End User
5.4.2 Rest of North America Obesity Intervention Devices Market by Device
Chapter 6. Company Profiles
6.1 Johnson & Johnson
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental &Regional Analysis
6.1.4 Research & Development Expenses
6.2 Apollo Endosurgery, Inc. (Boston Scientific Corporation)
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expenses
6.2.5 Recent strategies and developments:
6.2.5.1 Approvals and Trials:
6.3 ReShape Lifesciences, Inc.
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Regional Analysis
6.3.4 Research and Development Expense
6.3.5 Recent strategies and developments:
6.3.5.1 Approvals and Trials:
6.4 AbbVie, Inc.
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Regional Analysis
6.4.4 Research & Development Expense
6.5 Allurion Technologies, Inc.
6.5.1 Company Overview
6.5.2 Recent strategies and developments:
6.5.2.1 Approvals and Trials:
6.5.2.2 Product Launches and Product Expansions:
6.6 Spatz FGIA, Inc.
6.6.1 Company Overview
6.6.2 Recent strategies and developments:
6.6.2.1 Approvals and trials:
6.7 Cousin Surgery
6.7.1 Company Overview
6.8 A.M.I. GmbH
6.8.1 Company Overview
6.9 ENDALIS
6.9.1 Company Overview
6.10. GI Dynamics, Inc.
6.10.1 Company Overview
TABLE 1 North America Obesity Intervention Devices Market, 2019 - 2022, USD Million
TABLE 2 North America Obesity Intervention Devices Market, 2023 - 2029, USD Million
TABLE 3 North America Obesity Intervention Devices Market by End User, 2019 - 2022, USD Million
TABLE 4 North America Obesity Intervention Devices Market by End User, 2023 - 2029, USD Million
TABLE 5 North America Hospitals Market by Country, 2019 - 2022, USD Million
TABLE 6 North America Hospitals Market by Country, 2023 - 2029, USD Million
TABLE 7 North America Clinics & Others Market by Country, 2019 - 2022, USD Million
TABLE 8 North America Clinics & Others Market by Country, 2023 - 2029, USD Million
TABLE 9 North America Obesity Intervention Devices Market by Device, 2019 - 2022, USD Million
TABLE 10 North America Obesity Intervention Devices Market by Device, 2023 - 2029, USD Million
TABLE 11 North America Gastric Bands Market by Country, 2019 - 2022, USD Million
TABLE 12 North America Gastric Bands Market by Country, 2023 - 2029, USD Million
TABLE 13 North America Gastric Balloon Market by Country, 2019 - 2022, USD Million
TABLE 14 North America Gastric Balloon Market by Country, 2023 - 2029, USD Million
TABLE 15 North America Gastric Stimulation System Market by Country, 2019 - 2022, USD Million
TABLE 16 North America Gastric Stimulation System Market by Country, 2023 - 2029, USD Million
TABLE 17 North America Obesity Intervention Devices Market by Country, 2019 - 2022, USD Million
TABLE 18 North America Obesity Intervention Devices Market by Country, 2023 - 2029, USD Million
TABLE 19 US Obesity Intervention Devices Market, 2019 - 2022, USD Million
TABLE 20 US Obesity Intervention Devices Market, 2023 - 2029, USD Million
TABLE 21 US Obesity Intervention Devices Market by End User, 2019 - 2022, USD Million
TABLE 22 US Obesity Intervention Devices Market by End User, 2023 - 2029, USD Million
TABLE 23 US Obesity Intervention Devices Market by Device, 2019 - 2022, USD Million
TABLE 24 US Obesity Intervention Devices Market by Device, 2023 - 2029, USD Million
TABLE 25 Canada Obesity Intervention Devices Market, 2019 - 2022, USD Million
TABLE 26 Canada Obesity Intervention Devices Market, 2023 - 2029, USD Million
TABLE 27 Canada Obesity Intervention Devices Market by End User, 2019 - 2022, USD Million
TABLE 28 Canada Obesity Intervention Devices Market by End User, 2023 - 2029, USD Million
TABLE 29 Canada Obesity Intervention Devices Market by Device, 2019 - 2022, USD Million
TABLE 30 Canada Obesity Intervention Devices Market by Device, 2023 - 2029, USD Million
TABLE 31 Mexico Obesity Intervention Devices Market, 2019 - 2022, USD Million
TABLE 32 Mexico Obesity Intervention Devices Market, 2023 - 2029, USD Million
TABLE 33 Mexico Obesity Intervention Devices Market by End User, 2019 - 2022, USD Million
TABLE 34 Mexico Obesity Intervention Devices Market by End User, 2023 - 2029, USD Million
TABLE 35 Mexico Obesity Intervention Devices Market by Device, 2019 - 2022, USD Million
TABLE 36 Mexico Obesity Intervention Devices Market by Device, 2023 - 2029, USD Million
TABLE 37 Rest of North America Obesity Intervention Devices Market, 2019 - 2022, USD Million
TABLE 38 Rest of North America Obesity Intervention Devices Market, 2023 - 2029, USD Million
TABLE 39 Rest of North America Obesity Intervention Devices Market by End User, 2019 - 2022, USD Million
TABLE 40 Rest of North America Obesity Intervention Devices Market by End User, 2023 - 2029, USD Million
TABLE 41 Rest of North America Obesity Intervention Devices Market by Device, 2019 - 2022, USD Million
TABLE 42 Rest of North America Obesity Intervention Devices Market by Device, 2023 - 2029, USD Million
TABLE 43 Key information –Johnson & Johnson
TABLE 44 Key Information – Apollo Endosurgery, Inc.
TABLE 45 Key Information – ReShape Lifesciences, Inc.
TABLE 46 Key information – AbbVie, Inc.
TABLE 47 key information – Allurion Technologies, Inc.
TABLE 48 Key Information – Spatz FGIA, Inc.
TABLE 49 Key Information – Cousin Surgery
TABLE 50 Key Information – A.M.I. GmbH
TABLE 51 Key Information – Endalis
TABLE 52 Key Information – GI Dynamics, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 North America Obesity Intervention Devices Market Share by End User, 2022
FIG 3 North America Obesity Intervention Devices Market Share by End User, 2029
FIG 4 North America Obesity Intervention Devices Market by End User, 2019 - 2029, USD Million
FIG 5 North America Obesity Intervention Devices Market Share by Device, 2022
FIG 6 North America Obesity Intervention Devices Market Share by Device, 2029
FIG 7 North America Obesity Intervention Devices Market by Device, 2019 - 2029, USD Million
FIG 8 North America Obesity Intervention Devices Market Share by Country, 2022
FIG 9 North America Obesity Intervention Devices Market Share by Country, 2029
FIG 10 North America Obesity Intervention Devices Market by Country, 2019 - 2029, USD Million
FIG 11 SWOT analysis: Johnson & Johnson